Table 3: Comorbidities in the two studied groups.
|
|
Simultaneous (n= 20) |
Staged (n= 20) |
χ2 value |
P value |
|
No |
2 (10.0%) |
8 (40.0%) |
4.800 |
0.028 |
|
Yes |
18 (90.0%) |
12 (60.0%) |
||
|
HTN |
16 (80.0%) |
10 (50.0%) |
3.956 |
0.047 |
|
DM |
8 (40.0%) |
6 (30.0%) |
0.440 |
0.507 |
|
Asthma |
0 (0.0%) |
1 (5.0%) |
1.026 |
0.311 |
|
Hyperthyroidism |
1 (5.0%) |
1 (5.0%) |
---- |
---- |
|
Hypothyroidism |
1 (5.0%) |
1 (5.0%) |
---- |
---- |
|
COPD |
0 (0.0%) |
1 (5.0%) |
1.026 |
0.311 |
|
CHB |
1 (5.0%) |
1 (5.0%) |
---- |
---- |
|
Hemorroid |
0 (0.0%) |
1 (5.0%) |
1.026 |
0.311 |
|
Renal impairment/ impairment |
1 (5.0%) |
1 (5.0%) |
---- |
---- |
|
Old CVA |
1 (5.0%) |
0 (0.0%) |
1.026 |
0.311 |
|
Prostatic hypertrophy |
0 (0.0%) |
1 (5.0%) |
1.026 |
0.311 |
Data are expressed as number (%).
χ2= Chi square test.
p> 0.05= not significant.
p≤ 0.05= significant.